These genes included CAPZB, DSTN, GYS1, IQGAP1, MYH9, NDUFA11, NDUFS1, OXSM (Figure 4B–D, Table 2), which were then utilized to establish a prognostic model for DLBCL patients. The gene discussed is NDUFA11; the disease is diffuse large B-cell lymphoma.